Aerpio Pharmaceuticals In... (ARPO)
NASDAQ: ARPO
· Real-Time Price · USD
2.20
-0.02 (-0.90%)
At close: Aug 27, 2021, 6:00 AM
Aerpio Pharmaceuticals Revenue Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|
| Product Revenue | 7.14M | 12.59M | 7.21M | 6.18M |
| Product Revenue Growth | -43.26% | +74.60% | +16.72% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 5.94M | 12.81M | 28.28M | 7.19M | 7.89M | 3.58M | 2.35M | 2.54M | 1.81M | 1.56M | 2.08M | 1.98M | 2.22M | 1.77M | 2.14M | 2.15M | 1.98M | 1.84M | 1.97M | 2.17M | 3.54M | 3.76M | 1.58M | 780K | 2.21M | 514K | 557K | 639K |
| Selling, General, and Administrative Revenue Growth | -53.65% | -54.68% | +293.52% | -8.95% | +120.26% | +52.47% | -7.41% | +40.22% | +15.95% | -25.06% | +5.04% | -10.80% | +25.74% | -17.34% | -0.56% | +8.80% | +7.15% | -6.49% | -9.12% | -38.76% | -5.67% | +137.55% | +102.82% | -64.71% | +329.96% | -7.72% | -12.83% | n/a |
| Research and Development Revenue | 48.81M | 8.79M | 25.19M | 10M | 13.09M | 7.98M | 8.26M | 9.6M | 9.57M | 8.4M | 9.02M | 8.03M | 4.81M | 5.63M | 5.22M | 4.35M | 4.98M | 4.07M | 2.65M | 2.75M | 1.67M | 3.02M | 3.08M | 2.06M | 1.98M | 1.92M | 2.29M | 8.95M |
| Research and Development Revenue Growth | +455.41% | -65.11% | +151.97% | -23.65% | +64.11% | -3.40% | -14.00% | +0.37% | +13.92% | -6.87% | +12.36% | +66.76% | -14.43% | +7.67% | +20.11% | -12.65% | +22.48% | +53.55% | -3.71% | +64.87% | -44.75% | -1.85% | +49.25% | +3.88% | +3.60% | -16.23% | -74.47% | n/a |